1. My Treatment Approach to Rheumatoid Arthritis
John M. Davis, MD, Eric L. Matteson, MD, MPH 
Mayo Clinic Proceedings 
Volume 87, Issue 7, Pages (July 2012)
DOI: /j.mayocp
Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions

2. FIGURE 1
Our treatment approach to newly diagnosed rheumatoid arthritis (RA) from baseline to 6 months of follow-up. ACR/EULAR 2010 = American College of Rheumatology/European League Against Rheumatism 2010 Classification Criteria for RA; CDAI = Clinical Disease Activity Index; CTLA4:Ig = cytotoxic T lymphocyte–associated antigen 4:immunoglobulin fusion protein; HCQ = hydroxychloroquine; LEF = leflunomide; MTX = methotrexate; Rx = prescription; SC = subcutaneous; SDAI = Simplified Disease Activity Index; SSZ = sulfasalazine; TNF = tumor necrosis factor.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions

3. FIGURE 2
Our treatment approach to early rheumatoid arthritis (RA) from 6 months to 1 year. anti–IL-6R = anti-interleukin 6 receptor; CDAI = Clinical Disease Activity Index; CTLA4:Ig = cytotoxic T lymphocyte–associated antigen 4:immunoglobulin fusion protein; DMARD = disease-modifying antirheumatic drug; HCQ = hydroxychloroquine; mAb = monoclonal antibody; MTX = methotrexate; Rx = prescription; SC = subcutaneous; SDAI = Simplified Disease Activity Index; SSZ = sulfasalazine; TNF = tumor necrosis factor.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions

4. FIGURE 3
Our approach to treatment of rheumatoid arthritis (RA) beyond the first year of disease. DMARD therapy refers to use of methotrexate (MTX) and other conventional disease-modifying antirheumatic drugs. Biologic therapy refers to treatment with tumor necrosis factor (TNF) inhibitors, abatacept, rituximab, tocilizumab, or anakinra. anti–IL-6R = anti-interleukin 6 receptor; CDAI = Clinical Disease Activity Index; CTLA4:Ig = cytotoxic T lymphocyte–associated antigen 4:immunoglobulin fusion protein; HCQ = hydroxychloroquine; IL-1ra = interleukin 1 receptor antagonist; LEF = leflunomide; mAb = monoclonal antibody; Rx = prescription; SDAI = Simplified Disease Activity Index; SSZ = sulfasalazine.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions